Author Archives: Science Media Centre
expert reaction to the Government’s COVID-19 Winter Plan
The government have released a COVID-19 Winter Plan. Dr Julian Tang, Honorary Associate Professor/ Clinical Virologist, Respiratory Sciences, University … read more
AstraZeneca and University of Oxford media briefing
Journalists from around the world were invited to join a media briefing webinar on the positive high-level results from an … read more
expert reaction to phase 3 interim analysis of the Oxford/AstraZeneca COVID-19 vaccine
Experts commented on the phase 3 interim analysis of the Oxford / AstraZeneca COVID-19 vaccine read more
AstraZeneca Antibody Study
We have heard a lot about vaccines for the elderly. But there are also prophylactic drugs being tested that could … read more
expert reaction to preprint looking at COVID-19 antibodies and protection against reinfection
A preprint, an unpublished non-peer reviewed study, posted on medRxiv looks at antibodies to SARS-CoV-2 and protection against reinfection. … read more
expert reaction to study looking at MMR antibodies and COVID-19 disease severity
A study published in mBio looks at Measles-Mumps-Rubella (MMR) antibodies and COVID-19 disease severity. Dr Penny Ward, Visiting Professor … read more
expert reaction to latest R number and growth rate estimates published by the government
The government have released the latest estimates for the COVID-19 growth rate and R value. Prof Oliver Johnson, Professor … read more
expert reaction to latest data from the ONS COVID-19 Infection Survey
The Office for National Statistics (ONS) have released the latest data from their COVID-19 Infection Survey. Dr Simon Clarke, Associate … read more
expert comments about COVID-19 and Christmas
A few journalists have asked us what COVID-19 means for Christmas this year, so here a few general comments from … read more
expert reaction to WHO Guideline Development Group advising against use of remdesivir for COVID-19
The World Health Organisation (WHO) have released an updated guideline on drugs for COVID-19, published in the BMJ, in which … read more
expert reaction to a preprint on responsive T cell numbers and associated protection from COVID-19, as referred to in the PHE ‘Evaluating detection of SARS-CoV-2: AntiBodies at Home study’ report which was updated yesterday
A preprint, an unpublished non-peer reviewed study, posted on MedRxiv looks at responsive T cell numbers and associated protection from … read more
expert reaction to REMAP-CAP trial reporting that critically ill COVID-19 patients treated with tocilizumab are more likely to have improved outcomes
The REMAP-CAP trial has reported that critically ill COVID-19 patients treated with tocilizumab are more likely to have improved outcomes. … read more
results from REMAP-CAP trial – tocilizumab for patients with severe COVID-19
The REMAP-CAP trial, which began investigating treatments for COVID-19 in March, has been trialling potential treatments in hospitalised patients with … read more
phase 2 trial safety and immunogenicity data from the Oxford COVID-19 vaccine trial including in healthy older adults
The Oxford vaccine have published data from the phase 2 trial of their COVID-19 vaccine candidate, the ChAdOx1 nCoV-19 vaccine. … read more
expert reaction to paper using an RCT to assess mask use as a public health measure to help control SARS-CoV-2 spread (DANMASK-19)
A randomised control trial (RCT) published by Annals of Internal Medicine assesses mask use as a public health measure to … read more
expert reaction to phase 2 trial safety and immunogenicity data from the Oxford COVID-19 vaccine trial including in healthy older adults
The phase 2 trial safety and immunogenicity data from the Oxford COVID-19 vaccine trial has been published in the Lancet, … read more
expert reaction to announcement by Pfizer that they have concluded the Phase III study of their COVID-19 vaccine candidate after demonstrating 95% efficacy
Pfizer and BioNTech have announced that they have concluded phase 3 study of their COVID-19 vaccine candidate, demonstrating 95% efficacy. … read more
expert reaction to a preprint investigating immunological memory to SARS-CoV-2 after six months
A preprint, an unpublished non-peer reviewed study, posted on bioRxiv looks at immunological memory to SARS-CoV-2 over six months after … read more
expert reaction to the government’s ‘ten point plan for a Green Industrial Revolution’
Boris Johnson has announced the government’s ten point plan for a green economy, jobs and industry. Prof Rob Gross, … read more